Sinusitis, Chronic
10
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Microbiota Transfer for Chronic Rhinosinusitis
Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults
Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)
"Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".
GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery
Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
Houston "Breathe Easy" Healthy Homes-Based Model for Multifamily Rental Communities
Effect of Postoperative Additive Systemic Steroids in CRSwNP
Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention
SynRinse Irrigation Pilot (SIP) Trial